Group Purchasing Channel Adapt Pharma operates NARCANDirect, an online platform for qualifying group purchasers of Narcan Nasal Spray, including law enforcement, first responders, departments of health, and educational facilities. This channel offers sales opportunities to expand into additional states and agencies with bulk pricing, standing orders, and streamlined replenishment, complemented by procurement-friendly training and compliance materials.

Institutional Outreach Historical partnerships with schools and community campaigns indicate strong potential to scale distribution to educational institutions, healthcare facilities, EMS and public health programs through turnkey implementation, logistics support, and on-site training that smooths procurement and adoption.

Channel Partnerships Past distribution partnerships and an acquisition history suggest opportunity to re-engage healthcare distributors, government contractors, and OEM partners to broaden Narcan reach, with co-branding or white-label arrangements and targeted incentives for large-volume contracts.

International Growth With a global HQ in Dublin and a US-focused track record, Adapt Pharma could pursue international expansion via licensing, regional distribution agreements, or direct sales to public health systems, leveraging existing regulatory know-how and partner ecosystems to accelerate market entry.

Growth Readiness As a small company with modest revenue and a lean team, there is value in building scalable procurement programs, training services, and joint marketing with partners to increase volumes, while evaluating additional naloxone product formats or related overdose-prevention offerings to diversify revenue streams.